cas 1065010-88-9|| where to buy Potassium cyclobutyltrifluoroborate

Nom du produit:Potassium cyclobutyltrifluoroborate

IUPAC Name:potassium cyclobutyltrifluoroboranuide

Unité d'emballage	Stock disponible	Prix($)
CM204613-1g	in stock	ȬƎ
CM204613-5g	in stock	ưȺư
CM204613-10g	in stock	țȺȬ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1065010-88-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1065010-88-9; Formule moléculaire:C4H7BF3K; Point de fusion:-; Code SMILES:F[B-](F)(C1CCC1)F.[K+]; Densité:

: Numéro de catalogue:CM204613; Poids moléculaire:162; Point d'ébullition:; N° Mdl:MFCD09992884; Stockage:Store at 2-8°C.

: Borates; Borates are classified as critical materials, they are the main source of boron and have a variety of industrial applications. Organic trifluoroborate is stable to heat, air and humidity, and is a very convenient crystalline boric acid compound. Since it has a tetra-coordinated boronic acid structure after the substitution of fluorine, it does not exhibit Lewis acidity and is stable to oxidation conditions. In addition, it can be regarded as the protector of boronic acid and boronic acid ester, which can be converted into each other. The compound can generally exist stably in organic solvents, but will decompose in protic solvents to liberate trivalent boron, so it can be directly used as a substrate for Suzuki coupling. The difference between trifluoroborate and boric acid is that it must exist in a monomeric form, so the equivalent weight can be closely controlled.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.